{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:47:34Z","timestamp":1791546454976,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.plefa.2009.10.007","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T02:51:46Z","timestamp":1259376706000},"page":"9-14","source":"Crossref","is-referenced-by-count":68,"title":["Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder"],"prefix":"10.1016","volume":"82","author":[{"given":"Pieter","family":"Stolk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"Souverein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Wilting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert G.M.","family":"Leufkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald F.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley I.","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eibert R.","family":"Heerdink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.plefa.2009.10.007_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1399-5618.2005.00216.x","article-title":"Clinical correlates and significance of separation anxiety in patients with bipolar disorder","volume":"7","author":"Pini","year":"2005","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.plefa.2009.10.007_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1990.tb08813.x","article-title":"Arachidonic acid cascade and signal transduction","volume":"55","author":"Shimizu","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.plefa.2009.10.007_bib3","doi-asserted-by":"crossref","unstructured":"J.S. Rao, J. Harry, S.I. Rapoport, H.-W. Kim, Increased excitotoxicity markers and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients, Mol. Psychiatry. (2 June 2009 Electronic Publication).","DOI":"10.1038\/mp.2009.47"},{"key":"10.1016\/j.plefa.2009.10.007_bib4","unstructured":"H.-W. Kim, S.I. Rapoport, J.S. Rao, Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients, Mol. Psychiatry, in press."},{"issue":"1-3","key":"10.1016\/j.plefa.2009.10.007_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-0327(01)00380-9","article-title":"Lithium treatment at 52","volume":"67","author":"Schou","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.plefa.2009.10.007_bib6","series-title":"Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression","author":"Goodwin","year":"2007"},{"issue":"8","key":"10.1016\/j.plefa.2009.10.007_bib7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.mp.4001518","article-title":"Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers","volume":"9","author":"Gould","year":"2004","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.plefa.2009.10.007_bib8","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0028-3908(00)00051-4","article-title":"The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro","volume":"39","author":"Cunningham","year":"2000","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.plefa.2009.10.007_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(96)00265-8","article-title":"Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications","volume":"307","author":"Stefani","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.plefa.2009.10.007_bib10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archpsyc.59.7.592","article-title":"Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?","volume":"59","author":"Rapoport","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.plefa.2009.10.007_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(96)13264-X","article-title":"Lithium decreases turnover of arachidonate in several brain phospholipids","volume":"220","author":"Chang","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"5-6","key":"10.1016\/j.plefa.2009.10.007_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.plefa.2007.10.018","article-title":"Antimanic therapies target brain arachidonic acid signaling: Lessons learned about the regulation of brain fatty acid metabolism","volume":"77","author":"Lee","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"6","key":"10.1016\/j.plefa.2009.10.007_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mp.2008.31","article-title":"Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?","volume":"13","author":"Rao","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.plefa.2009.10.007_bib14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11064-007-9526-3","article-title":"Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex","volume":"33","author":"Lee","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.plefa.2009.10.007_bib15","doi-asserted-by":"crossref","unstructured":"S.I. Rapoport, Basselin, M., Kim, H.-W., Rao, J.S. Bipolar disorder and mechanisms of action of mood stabilizers, Brain Res. Rev. 61 (2) (2009) 185\u2013209.","DOI":"10.1016\/j.brainresrev.2009.06.003"},{"issue":"5","key":"10.1016\/j.plefa.2009.10.007_bib16","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1471-4159.2003.02246.x","article-title":"Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide","volume":"88","author":"Rosenberger","year":"2004","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.plefa.2009.10.007_bib17","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/j.1471-4159.2007.04648.x","article-title":"Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A(2) and its transcription factor, activator protein-2","volume":"102","author":"Rao","year":"2007","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.plefa.2009.10.007_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1471-4159.2007.04593.x","article-title":"Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation","volume":"102","author":"Basselin","year":"2007","journal-title":"J. Neurochem."},{"issue":"13","key":"10.1016\/j.plefa.2009.10.007_bib19","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.plefa.2009.10.007_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1357-4310(97)88908-3","article-title":"Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis","volume":"3","author":"Buckingham","year":"1997","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.plefa.2009.10.007_bib21","unstructured":"K.K. Wu, Novel mechanisms of aspirin pharmacologic actions: a model for studying herbal natural products, Thromb. Res. 117 (1\u20132) (2005) 61\u201364; discussion 65\u201367"},{"key":"10.1016\/j.plefa.2009.10.007_bib22","unstructured":"R. Herings, PHARMO: a record of lingage system for postmarketing surveillance of prescription drugs in the Netherlands, Thesis, 1993."},{"key":"10.1016\/j.plefa.2009.10.007_bib23","unstructured":"PHARMO Record Linkage System. \u3008http:\/\/www.pharmonl\/framesphp?htmlpage=navigatie\/databaseshtm\u3009 (accessed May 30, 2008)."},{"key":"10.1016\/j.plefa.2009.10.007_bib24","unstructured":"Anatomical Therapeutic Chemical Classification System. \u3008http:\/\/www.whoccno\/atcddd\/\u3009 (accessed October 31, 2007)."},{"issue":"9","key":"10.1016\/j.plefa.2009.10.007_bib25","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/S0021-9258(18)53294-4","article-title":"Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs","volume":"268","author":"Meade","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.plefa.2009.10.007_bib26","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell\u2013leukocyte interactions","volume":"92","author":"Claria","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.plefa.2009.10.007_bib27","first-page":"25","article-title":"Regulation of prostaglandin synthesis by glucocorticoids","volume":"4","author":"Masferrer","year":"1994","journal-title":"Receptor"},{"issue":"5","key":"10.1016\/j.plefa.2009.10.007_bib28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/j.1440-1614.2006.01815.x","article-title":"Anticonvulsants in bipolar disorder","volume":"40","author":"Bowden","year":"2006","journal-title":"Aust. NZ J. Psychiatry"},{"issue":"2","key":"10.1016\/j.plefa.2009.10.007_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0895-4356(92)90016-G","article-title":"A chronic disease score from automated pharmacy data","volume":"45","author":"Von Korff","year":"1992","journal-title":"J. Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.plefa.2009.10.007_bib30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00005650-199508000-00004","article-title":"A chronic disease score with empirically derived weights","volume":"33","author":"Clark","year":"1995","journal-title":"Med. Care"},{"issue":"6","key":"10.1016\/j.plefa.2009.10.007_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/YIC.0b013e3282202c0e","article-title":"No increased incidence of diabetes in antidepressant users","volume":"22","author":"Knol","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.plefa.2009.10.007_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000542-200502000-00026","article-title":"Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans","volume":"102","author":"Dembo","year":"2005","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.plefa.2009.10.007_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0022-3999(95)00524-2","article-title":"Is aspirin, as used for antithrombosis, an emotion-modulating agent?","volume":"40","author":"Ketterer","year":"1996","journal-title":"J. Psychosom. Res."},{"issue":"Suppl. 5","key":"10.1016\/j.plefa.2009.10.007_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1399-5618.2005.00248.x","article-title":"Identifying and improving non-adherence in bipolar disorders","volume":"7","author":"Colom","year":"2005","journal-title":"Bipolar Disord."},{"issue":"24","key":"10.1016\/j.plefa.2009.10.007_bib35","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.90.24.11693","article-title":"Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase","volume":"90","author":"Mitchell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.plefa.2009.10.007_bib36","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1073\/pnas.96.9.5292","article-title":"Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate","volume":"96","author":"Xu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.plefa.2009.10.007_bib37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.CIR.86.1.56","article-title":"Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy","volume":"86","author":"Brezinski","year":"1992","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.plefa.2009.10.007_bib38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.plefa.2009.10.007_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/ejcn.2008.81","article-title":"Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation","author":"Clayton","year":"2009","journal-title":"Eur. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.plefa.2009.10.007_bib40","first-page":"207","article-title":"Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural\u2013functional synergies with cell membrane phospholipids","volume":"12","author":"Kidd.","year":"2007","journal-title":"Altern. Med. Rev."},{"issue":"7","key":"10.1016\/j.plefa.2009.10.007_bib41","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4088\/JCP.v68n0712","article-title":"A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids","volume":"68","author":"Lin","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.plefa.2009.10.007_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/j.1440-1614.2006.01813.x","article-title":"Antiglucocorticoid treatments for depression","volume":"40","author":"Young","year":"2006","journal-title":"Aust. NZ J. Psychiatry"},{"issue":"5","key":"10.1016\/j.plefa.2009.10.007_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/10673229809000307","article-title":"Mood symptoms during corticosteroid therapy: a review","volume":"5","author":"Brown","year":"1998","journal-title":"Harv. Rev. Psychiatry"},{"issue":"10 Suppl. 2","key":"10.1016\/j.plefa.2009.10.007_bib44","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/MLR.0b013e318041f752","article-title":"Methodologic challenges to studying patient safety and comparative effectiveness","volume":"45","author":"Strom","year":"2007","journal-title":"Med. Care"},{"issue":"2","key":"10.1016\/j.plefa.2009.10.007_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.clpt.6100249","article-title":"Developments in post-marketing comparative effectiveness research","volume":"82","author":"Schneeweiss","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.plefa.2009.10.007_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s100670050114","article-title":"Non-steroidal anti-inflammatory drugs with adverse psychiatric reactions: five case reports","volume":"18","author":"Jiang","year":"1999","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.plefa.2009.10.007_bib47","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s10067-006-0407-y","article-title":"Anxiety and depression in patients with rheumatoid arthritis","volume":"26","author":"Isik","year":"2007","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.plefa.2009.10.007_bib48","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.4088\/JCP.v64n1108","article-title":"Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs","volume":"64","author":"Phelan","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.plefa.2009.10.007_bib49","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1185\/030079907X187883","article-title":"The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for medicaid enrollees with schizophrenia","volume":"23","author":"Chen","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"issue":"Suppl.","key":"10.1016\/j.plefa.2009.10.007_bib50","first-page":"4","article-title":"Lithium: the present and the future","volume":"51","author":"Jefferson","year":"1990","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.plefa.2009.10.007_bib51","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/0165-0327(85)90085-0","article-title":"Present status of drug therapy of depression in late life","author":"Gerner","year":"1985","journal-title":"J. Affect Disord."},{"issue":"3","key":"10.1016\/j.plefa.2009.10.007_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-977714","article-title":"The association between exposure to COX-2 inhibitors and schizophrenia deterioration. A nested case-control study","volume":"40","author":"Stolk","year":"2007","journal-title":"Pharmacopsychiatry"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232780900177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232780900177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T23:45:14Z","timestamp":1634255114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095232780900177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S095232780900177X"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2009.10.007","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}